Clinical trialNCT05557708Not, yet, recruitingEarly phase 1Interventional

A Safety Study of 212Pb-Pentixather Radioligand Therapy

SponsorYusuf MendaEnrollment20Carcinoid Tumor LungCarcinoma, Small-Cell LungNeuroendocrine Tumor of the Lung

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a first-in-human clinical trial evaluating the safety of an alpha-radiation treatment (Lead-212 labelled Pentixather) in patients who have been diagnosed with, and previously treated, for atypical carcinoid lesions of the lung.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Yusuf Menda, MD
University of Iowa
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Iowa Health Care
Iowa City, Iowa, United States
David Bushnell, MDJoseph Dillon, MDMichael Graham, MD, Ph.D.Stephen Graves, PhDYusuf Menda, MD

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

212-Lead Pentixather

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Jul 2026
Primary completion: 30 Jun 2028
Completion: 30 Jun 2030
Last update posted: 8 Jul 2025
Registered enrollment: 20
Registry id: NCT05557708

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.